Professur für Immunologie

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic (2022) Hoffmann M, Krüger N, Schulz S, Cossmann A, Rocha C, Kempf A, Nehlmeier I, et al. Journal article No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2 (2022) Arora P, Kempf A, Nehlmeier I, Graichen L, Winkler MS, Lier M, Schulz S, et al. Journal article IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation (2021) Faas M, Ipseiz N, Ackermann J, Culemann S, Grüneboom A, Schröder F, Rothe T, et al. Journal article B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination (2021) Arora P, Sidarovich A, Krüger N, Kempf A, Nehlmeier I, Graichen L, Moldenhauer AS, et al. Journal article A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants (2021) Vesper N, Ortiz Y, Bartels-Burgahn F, Yang J, De La Rosa K, Tenbusch M, Schulz S, et al. Journal article A pair of non‐competing neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model (2021) Peter AS, Roth E, Schulz S, Fraedrich K, Steinmetz T, Damm D, Hauke M, et al. Journal article, Original article The role of glucose transporter type 1 in plasma cells (2021) Bierling T, Gumann A, Van Schie K, Wichert M, Hauke M, Wittner J, Schuh W, et al. Conference contribution SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination (2021) Hoffmann M, Hofmann-Winkler H, Krüger N, Kempf A, Nehlmeier I, Graichen L, Arora P, et al. Journal article Complement Activation in Kidneys of Patients With COVID-19 (2021) Pfister F, Vonbrunn E, Ries T, Jäck HM, Überla K, Lochnit G, Sheriff A, et al. Journal article Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability (2021) Burnett DL, Jackson KJ, Langley DB, Aggrawal A, Stella AO, Johansen MD, Balachandran H, et al. Journal article